Browsing by Subject
Ara mostrant els elements 1-20 d 373
-
2023 GEIS Guidelines for gastrointestinal stromal tumors
(SAGE Publications, 2023) -
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors
(Oxford University Press, 2024-01) -
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
(American Association for Cancer Research, 2022-06-01) -
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors
(American Association for Cancer Research, 2023-09-14) -
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
(American Association for Cancer Research, 2023-01-17) -
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer
(Oxford University Press, 2023-03) -
A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer
(Future Medicine, 2023-08) -
A pragmatic guide for management of adverse events associated with lorlatinib
(Elsevier, 2024-03-14) -
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
(Lippincott Williams & Wilkins, 2022-12-01)